Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214175 · ClinicalTrials.gov registry record
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 44
- Enrollment target
NCT00214175 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 44 participants.
The verdict
NCT00214175 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions based on activation maps obtained with different thresholds in patients with benign and biopsy proven low-grade brain neoplasms. Another objective is to access the impairment in neurological function in image guided intracranial radiotherapy using neurocognitive assessment tools and to derive dose response curves relating the impairment in a particular neurological function to the FED received by the area of eloquent brain corresponding to it.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2004-06 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00214175
The ClinicalTrials.gov registry entry for NCT00214175 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00214175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00214175 about?
NCT00214175 is a clinical study titled "Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy". The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions based on activation maps obtained with different thresholds in patients with benign and biopsy prove...
What is the current status of trial NCT00214175?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2004-06. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00214175?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.